Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more. 
Via Benzinga
Topics Government
Study Shows Psychedelic Use Could Lower Chances of Suffering Frequent Headaches
Via Investor Brand Network
Study Suggests Psilocybin Can Treat Mild Concussions
Via Investor Brand Network
Why Guilt, Shame During Psychedelic Trips Could Actually Be Positive
Via Investor Brand Network
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
 
Via Benzinga
Seelos Therapeutics Delisted From Nasdaq, Will Transition To OTC Market
Seelos Therapeutics announces delisting from Nasdaq due to failure to meet equity requirements, with trading set to shift to OTC markets on October 16, 2024. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
 
Via Benzinga
Dow Dips 200 Points; Bank of America Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
Crude Oil Rises; Onconetix Shares Spike Higher
 
Via Benzinga
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected
 
Via Benzinga
Topics Economy
Dow Surges Over 100 Points; Costco Earnings Top Views
 
Via Benzinga
Topics Stocks
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”
Via AB Newswire
Crude Oil Gains Over 1%; BioVie Shares Plunge
 
Via Benzinga
What's Going On With Seelos Therapeutics Stock Tuesday?
Seelos shares are trading higher Tuesday after the company announced that it signed a material transfer agreement to supply SLS-002 for the Department of Defense's Military and Veterans Adaptative... 
Via Benzinga
Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
 
Via Benzinga
Dow Rises Over 50 Points; AutoZone Posts Downbeat Earnings
 
Via Benzinga
Topics Stocks
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024
SEEL stock results show that Seelos Therapeutics beat on revenue for the second quarter of 2024. 
Via InvestorPlace
US Stocks Edge Lower; Applied Materials Earnings Top Views
 
Via Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. 
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning! 
Via InvestorPlace
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
SEEL Stock Earnings: Seelos Therapeutics Beats EPS, Beats Revenue for Q1 2024
SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.